The store will not work correctly when cookies are disabled.
N-(oxetan-3-yl)-2-(pyridin-4-yl)-1,7-naphthyridin-4-amine
ID: ALA4483670
PubChem CID: 135368359
Max Phase: Preclinical
Molecular Formula: C16H14N4O
Molecular Weight: 278.32
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: c1cc(-c2cc(NC3COC3)c3ccncc3n2)ccn1
Standard InChI: InChI=1S/C16H14N4O/c1-4-17-5-2-11(1)14-7-15(19-12-9-21-10-12)13-3-6-18-8-16(13)20-14/h1-8,12H,9-10H2,(H,19,20)
Standard InChI Key: NKZPKBDVMKOULY-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 24 0 0 0 0 0 0 0 0999 V2000
11.1125 -5.9449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6740 -7.5740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0963 -7.5740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4008 -6.3535 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0963 -8.3868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2557 -7.5740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9814 -8.7932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2443 -9.6350 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8220 -8.7932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5171 -8.3842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5186 -10.0413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6740 -8.3868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2557 -8.3868 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2435 -8.7857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8220 -9.6350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9814 -7.1676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3996 -7.1676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3996 -8.7932 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9023 -6.1608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1166 -5.3686 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.3244 -5.1543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14 8 2 0
2 17 2 0
5 3 2 0
6 13 1 0
10 14 1 0
11 8 1 0
16 6 2 0
5 18 1 0
10 9 2 0
15 11 2 0
12 7 1 0
7 13 2 0
12 2 1 0
17 3 1 0
9 15 1 0
17 4 1 0
2 16 1 0
18 12 2 0
5 9 1 0
4 1 1 0
1 19 1 0
19 20 1 0
20 21 1 0
21 1 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 278.32 | Molecular Weight (Monoisotopic): 278.1168 | AlogP: 2.50 | #Rotatable Bonds: 3 |
Polar Surface Area: 59.93 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.79 | CX LogP: 1.04 | CX LogD: 1.04 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.80 | Np Likeness Score: -0.70 |
References
1. (2018) 6-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS Inhibitors, |